Informations sur le produit
Nom :
Fantofarone
Synonymes :
- 1-((p-(3-((3,4-Dimethoxyphenethyl)methylamino)propoxy)phenyl)sulfonyl)-2-isopropylindolizine
- 3,4-Dimethoxy-N-methyl-N-(3-(4-((2-(1-methylethyl)-1-indolizinyl)sulfonyl)phenoxy)propyl)benzeneethanmine
- 3,4-Dimethoxy-N-methyl-N-[3-[4-[[2-(1-methylethyl)-1-indolizinyl]sulfonyl]phenoxy]propyl]benzeneethanamine
- Benzeneethanamine, 3,4-dimethoxy-N-methyl-N-(3-(4-((2-(1-methylethyl)-1-indolizinyl)sulfonyl)phenoxy)propyl)-
- Fantofarona
- Fantofarona [INN-Spanish]
- Fantofarone [INN:BAN]
- Fantofaronum
- Fantofaronum [INN-Latin]
- N-[2-(3,4-dimethoxyphenyl)ethyl]-N-methyl-3-(4-{[2-(propan-2-yl)indolizin-1-yl]sulfonyl}phenoxy)propan-1-amine
- Voir d'autres synonymes
- Sr 33557
- Unii-Ku213Xyo69
Description :
Fantofarone is a calcium channel blocker that binds to the α1 subunit of the L-type calcium channel. It inhibits the release of neurotransmitters such as glutamate, which are associated with pain and other neurological symptoms. Fantofarone has not been shown to cause any cardiac side effects, but it has been shown to lower diastolic pressure and increase atrial and systolic pressure in some patients. The drug has been shown to decrease cerebellar Purkinje neurons in animal studies, but this effect has not been seen in humans. Fantofarone also blocks the release of neurotransmitters such as glutamate, which are associated with pain and other neurological symptoms.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
550.71 g/mol
Formule :
C31H38N2O5S
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
